A multicenter clinical randomized controlled trial, comparing of three different regimens of endovenous laser ablation with equal linear endovenous energy density in patients with insufficiency of the great saphenous vein (GSV). The linear endovenous energy density (LEED) is the main value for standardization EVLA. From many studies, it is known the optimum value of the LEED. However, the same LEED may be obtained by varying the ratio between the laser power and the fiber pullback speed. Power decrease can allow to reduce the incidence of adverse effects of endovenous laser ablation, but keep high efficiency.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
203
Endovenous laser ablation with laser wavelength 1470 nm and radial laser fiber
Device for endovenous laser ablation manufactured by Biolitec AG company (ELVeS system) - diode laser with a wavelength of 1470 nm
Clinic of Phlebology and Laser Surgery
Chelyabinsk, Russia
GarantClinic
Moscow, Russia
The number of participants with a fully obliterated target vein
An ultrasound investigation of the treated vein to find out is the treated vein is fully obliterated or not, and to find out is there any pathological reflux in the vein.
Time frame: 3 month
Pain score
Pain (numeric rating scale)
Time frame: day 1
Pain score
Pain (numeric rating scale)
Time frame: day 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.